HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Kojiro Ohba Selected Research
Kojiro Ohba Research Topics
Disease
45
Neoplasms (Cancer)
05/2024 - 03/2003
28
Renal Cell Carcinoma (Grawitz Tumor)
05/2024 - 05/2005
16
Neoplasm Metastasis (Metastasis)
04/2024 - 02/2006
11
Urinary Bladder Neoplasms (Bladder Cancer)
07/2021 - 02/2006
10
Prostatic Neoplasms (Prostate Cancer)
02/2024 - 01/2013
5
Overactive Urinary Bladder (Overactive Bladder)
07/2022 - 07/2016
4
Fatigue
04/2024 - 10/2015
4
Chronic Kidney Failure (Chronic Renal Failure)
11/2023 - 07/2019
4
Urologic Neoplasms (Urological Cancer)
09/2023 - 02/2013
4
Disease Progression
01/2022 - 08/2014
3
Anorexia
01/2023 - 12/2018
3
Lower Urinary Tract Symptoms
03/2022 - 07/2016
3
Non-Muscle Invasive Bladder Neoplasms
01/2022 - 01/2017
2
Chronic Renal Insufficiency
11/2023 - 07/2019
2
Pathologic Constriction (Stenosis)
12/2021 - 01/2016
2
Carcinogenesis
10/2021 - 08/2018
2
Pain (Aches)
10/2015 - 09/2012
1
Sigmoid Neoplasms
04/2024
1
Signet Ring Cell Carcinoma
04/2024
1
Nausea
04/2024
1
Colonic Neoplasms (Colon Cancer)
04/2024
1
Thrombosis (Thrombus)
01/2024
1
Ulcer
11/2023
1
Embolism (Embolus)
11/2023
1
Carcinoma (Carcinomatosis)
09/2023
1
Evans Syndrome
09/2023
1
Anemia
09/2023
1
Fever (Fevers)
09/2023
1
Pelvic Neoplasms
09/2023
1
Constipation
07/2022
1
Hypertension (High Blood Pressure)
03/2022
1
Hypercalciuria
03/2022
1
Atherosclerosis
12/2021
1
Renal Insufficiency (Renal Failure)
12/2021
Drug/Important Bio-Agent (IBA)
7
Nivolumab
IBA
05/2024 - 01/2019
7
Cisplatin (Platino)
FDA Link
Generic
12/2020 - 06/2011
6
Immune Checkpoint Inhibitors
IBA
05/2024 - 01/2019
6
royal jelly
IBA
12/2021 - 12/2018
6
Gemcitabine
FDA Link
11/2019 - 06/2011
5
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
11/2023 - 02/2006
5
Tyrosine Kinase Inhibitors
IBA
11/2023 - 12/2018
5
Paclitaxel (Taxol)
FDA Link
Generic
11/2019 - 12/2011
4
Axitinib (AG 013736)
IBA
11/2023 - 07/2020
4
Prostaglandins
IBA
10/2021 - 01/2013
4
Dinoprostone (PGE2)
FDA Link
10/2021 - 06/2006
3
Proteins (Proteins, Gene)
FDA Link
01/2023 - 01/2017
3
mirabegron
IBA
07/2022 - 07/2016
3
Sunitinib (Sutent)
FDA Link
01/2022 - 06/2018
3
Biomarkers (Surrogate Marker)
IBA
07/2021 - 12/2014
3
stage-specific embryonic antigen-4
IBA
07/2021 - 10/2019
2
C-Reactive Protein
IBA
04/2024 - 04/2021
2
Ipilimumab
IBA
04/2024 - 01/2024
2
Albumins
IBA
11/2023 - 04/2021
2
Cytokines
IBA
01/2023 - 01/2019
2
Macrophage Colony-Stimulating Factor
IBA
12/2021 - 10/2020
2
Polyphenols
IBA
01/2021 - 08/2018
2
Reactive Oxygen Species (Oxygen Radicals)
IBA
11/2020 - 10/2017
2
Heme Oxygenase-1
IBA
07/2020 - 01/2017
2
Tea
IBA
08/2018 - 07/2018
2
Antigens
IBA
07/2018 - 02/2017
2
Vascular Endothelial Growth Factors
IBA
01/2017 - 02/2006
2
Vascular Endothelial Growth Factor C
IBA
01/2017 - 02/2006
2
Formaldehyde (Formol)
FDA Link
11/2013 - 01/2013
2
Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
IBA
02/2013 - 01/2013
1
HLA-C Antigens (HLA-C)
IBA
05/2024
1
HLA-B Antigens (HLA-B)
IBA
05/2024
1
HLA-A Antigens (HLA-A)
IBA
05/2024
1
Bevacizumab (Avastin)
FDA Link
04/2024
1
Cholesterol
IBA
11/2023
1
pembrolizumab
IBA
09/2023
1
Antibodies
IBA
06/2023
1
Rituximab (Mabthera)
FDA Link
02/2023
1
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
01/2023
1
fesoterodine
FDA Link
07/2022
1
Cholinergic Antagonists (Anticholinergics)
IBA
07/2022
1
Calcium
IBA
03/2022
1
Mitomycin (Mitomycin-C)
FDA Link
Generic
01/2022
1
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2022
1
8-Hydroxy-2'-Deoxyguanosine
IBA
12/2021
Therapy/Procedure
28
Therapeutics
05/2024 - 12/2010
9
Nephrectomy
04/2024 - 08/2014
5
Drug Therapy (Chemotherapy)
04/2024 - 06/2011
4
Prostatectomy (Retropubic Prostatectomy)
01/2022 - 10/2017
3
Kidney Transplantation
02/2024 - 07/2019
3
Renal Replacement Therapy (Therapies, Renal Replacement)
12/2021 - 07/2019
3
Castration
09/2021 - 05/2009
3
Molecular Targeted Therapy
12/2020 - 08/2014
3
Aftercare (After-Treatment)
07/2016 - 09/2012
2
Combination Drug Therapy (Combination Chemotherapy)
12/2011 - 06/2011
1
Adjuvant Chemotherapy
04/2024
1
Lymph Node Excision (Lymph Node Dissection)
04/2024
1
Cystectomy
04/2024
1
Brachytherapy
02/2024
1
Neoadjuvant Therapy
01/2024
1
Blood Transfusion (Blood Transfusions)
12/2023
1
Thrombectomy
12/2023
1
Vascular Surgical Procedures
11/2023
1
Surgical Amputation (Amputations)
11/2023
1
Nephroureterectomy
09/2023
1
Renal Dialysis (Hemodialysis)
12/2021